(Q54210822)
Statements
A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. (English)
Bacteroides fragilis
1 reference
Ayers LW
Aldridge KE
Gelfand M
Reller LB
Pierson CL
Schoenknecht F
Tilton RC
Wilkins J
Henderberg A
Schiro DD
1 April 1994
18
4
235-241